Grünenthal Joins Munich's Nucleic Acid Therapeutics Innovation Hub to Enhance Genetic Medicine#Germany#Munich#Grünenthal#Nucleic_Acid#CNATM
Grünenthal Joins Munich's Nucleic Acid Therapeutics Innovation Hub to Enhance Genetic Medicine
Grünenthal has strengthened its capabilities in genetic medicine by joining the Munich Cluster for Nucleic Acid Therapeutics, aiming to innovate therapeutic solutions for patients.
third-news.com
July 16, 2026 at 8:24 AM
Grünenthal Joins Munich's Nucleic Acid Therapeutics Innovation Hub to Enhance Genetic Medicine#Germany#Munich#Grünenthal#Nucleic_Acid#CNATM
Exploring the Current Landscape of Nucleic Acid Medicines and mRNA Therapies: A Seminar on Nanoparticle DDS Development Trends#Japan#Tokyo#Nucleic_Acid#mRNA_Medicine#Nanoparticle_DDS
Exploring the Current Landscape of Nucleic Acid Medicines and mRNA Therapies: A Seminar on Nanoparticle DDS Development Trends
Join a live seminar discussing the latest trends in nucleic acid and mRNA medicines, focusing on nanoparticle DDS innovations. Expert insights await.
third-news.com
October 24, 2025 at 5:46 AM
Exploring the Current Landscape of Nucleic Acid Medicines and mRNA Therapies: A Seminar on Nanoparticle DDS Development Trends#Japan#Tokyo#Nucleic_Acid#mRNA_Medicine#Nanoparticle_DDS
Ferrotec Unveils Revolutionary Ferrobeads® DNA/RNA Isolation Kits for Improved Nucleic Acid Extraction#USA#Livermore#Nucleic_Acid#Ferrotec#Ferrobeads
Ferrotec Unveils Revolutionary Ferrobeads® DNA/RNA Isolation Kits for Improved Nucleic Acid Extraction
Ferrotec (USA) Corporation launched Ferrobeads® Quick Nucleic Acid Isolation Kits, enhancing nucleic acid extraction with improved efficiency and flexibility.
third-news.com
April 27, 2026 at 1:53 PM
Ferrotec Unveils Revolutionary Ferrobeads® DNA/RNA Isolation Kits for Improved Nucleic Acid Extraction#USA#Livermore#Nucleic_Acid#Ferrotec#Ferrobeads
Nucleic Acid Isolation and Purification Market Projected to Hit $10.99 Billion by 2030#USA#Delray_Beach#Purification#Nucleic_Acid#Isolation
Nucleic Acid Isolation and Purification Market Projected to Hit $10.99 Billion by 2030
The Nucleic Acid Isolation and Purification Market is on track to reach $10.99 billion by 2030, showcasing significant growth driven by diverse applications in clinical diagnostics and research.
third-news.com
January 20, 2026 at 5:19 PM
Nucleic Acid Isolation and Purification Market Projected to Hit $10.99 Billion by 2030#USA#Delray_Beach#Purification#Nucleic_Acid#Isolation
Revolutionizing Biomedical Research: Sampled and AutoGen Collaborate for Advanced Extraction Solutions#USA#Piscataway#Sampled#Nucleic_Acid#AutoGen
Revolutionizing Biomedical Research: Sampled and AutoGen Collaborate for Advanced Extraction Solutions
Sampled partners with AutoGen to enhance nucleic acid extraction and multifaceted analysis, aiming to advance biomedical research capabilities.
third-news.com
October 24, 2025 at 5:05 PM
Revolutionizing Biomedical Research: Sampled and AutoGen Collaborate for Advanced Extraction Solutions#USA#Piscataway#Sampled#Nucleic_Acid#AutoGen
Tsingke Biotech Hosts Pivotal Roundtable for Small Nucleic Acid Therapies in Beijing#China#Beijing#RNA_Therapies#Tsingke_Biotech#Nucleic_Acid
Tsingke Biotech Hosts Pivotal Roundtable for Small Nucleic Acid Therapies in Beijing
On July 26, 2025, Tsingke Biotech gathered experts in Beijing to discuss advances in small nucleic acid therapeutics and their commercialization.
third-news.com
July 29, 2025 at 6:34 AM
Tsingke Biotech Hosts Pivotal Roundtable for Small Nucleic Acid Therapies in Beijing#China#Beijing#RNA_Therapies#Tsingke_Biotech#Nucleic_Acid